Vernakalant Hydrochloride 20 mg/ml

Therapeutic Indication:

BRINAVESS is indicated in adults for rapid conversion of recent onset atrial fibrillation to sinus rhythm:

  • For non-surgery patients: atrial fibrillation ≤ 7 days duration.
  • For post-cardiac surgery patients: atrial fibrillation ≤ 3 days duration.


  • Composition: Vernakalant Hydrochloride 20 mg/ml.
  • Pharmaceutical Form: Concentrate for Solution for Infusion.
  • Method of Administration: Intravenous.
  • How Supplied: Single Vial of 10 ml (200 mg) or 25 ml (500 mg).
  • Manufacturer: Correvio International Sarl, Switzerland.

Contact Us

Contact us today to find out more about our services and discuss your enquiries.